Cftr modulators    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
299Cystic fibrosis6

299. Cystic fibrosis    [ 1,592 clinical trials,   1,539 drugs,   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways]
Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
6 / 1,592 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04580368
(ClinicalTrials.gov)
January 4, 20212/10/2020Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 TrialsTesting Drug Efficacy in Cystic Fibrosis Through N-of-1 TrialsCystic FibrosisDrug: CFTR ModulatorsChildren's Hospital Medical Center, CincinnatiNULLNot yet recruiting6 YearsN/AAll50N/ANULL
2NCT04415268
(ClinicalTrials.gov)
June 9, 202028/5/2020Combined Effect of CFTR Protein Modulator Drugs and Exercise in Cystic FibrosisCombined Effect of CFTR Protein Modulator Drugs and Exercise on Pulmonary Function, Fitness, Sweat Test and Quality of Life in Children With Cystic FibrosisCystic Fibrosis in ChildrenBehavioral: Exercise;Behavioral: Unsupervised exercise;Drug: CFTR ModulatorsUniversidad Europea de MadridNULLRecruiting6 Years18 YearsAll11N/ASpain
3NCT04301856
(ClinicalTrials.gov)
January 1, 202021/2/2020Response to CFTR Modulators in CF Patients Under 18 YearsEvaluation of the Response to CFTR Modulators in Patients With Cystic Fibrosis Less Than 18 Years of AgeCystic Fibrosis in ChildrenDrug: CFTR ModulatorsSociete Francaise de la MucoviscidoseNULLRecruitingN/A18 YearsAll600France
4NCT04206436
(ClinicalTrials.gov)
December 18, 201918/12/2019CFTR Modulator Effects on Bone and Muscle in Adults With Cystic FibrosisCFTR Modulator Effects on Bone and Muscle in Adults With Cystic FibrosisCystic Fibrosis;Bone Loss;Muscle LossDrug: Cftr ModulatorsIndiana UniversityCystic Fibrosis FoundationEnrolling by invitation18 YearsN/AAll60United States
5NCT03506061
(ClinicalTrials.gov)
September 4, 201913/4/2018Trikafta in Cystic Fibrosis PatientsiPS Cell Response to CFTR Modulators: Study of Trikafta in CF Patients Carrying Partial Function MutationsCystic FibrosisDrug: TrikaftaEmory UniversityNational Heart, Lung, and Blood Institute (NHLBI)Recruiting12 YearsN/AAll22Phase 2United States
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
6NCT01348204
(ClinicalTrials.gov)
March 20101/6/2010Nasal Potential Studies Utilizing Cystic Fibrosis Transmembrane Regulator (CFTR) ModulatorsNasal Potential Studies Utilizing CFTR Modulators (UAB Center for Clinical and Translational Science)Cystic FibrosisOther: quercetinUniversity of Alabama at BirminghamNational Institutes of Health (NIH)Completed8 Years65 YearsBoth32Phase 2United States